Literature DB >> 24014040

Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm.

Seong Hyeon Lee1, Jeong Su Baek, Joo Young Lee, Jung Ah Lim, Soo Youn Cho, Tae Hyun Lee, Yun Hyi Ku, Hong Il Kim, Min Joo Kim.   

Abstract

In cases of follicular neoplasm identified by thyroid fine-needle aspiration (FNA), surgery is required to achieve a precise diagnosis. We investigated potential clinical factors for the preoperative prediction of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm. We retrospectively reviewed the data of 97 patients who were diagnosed with follicular neoplasm by FNA and had undergone surgery at the Korea Cancer Center Hospital between April 2010 and April 2012. Age, sex, laboratory data (such as thyroid-stimulating hormone, free T4, thyroglobulin (Tg), and Tg antibody), and ultrasonographic findings were reviewed from the electronic medical records. Of 97 patients, 50 (51.5 %) were diagnosed with benign nodules, 16 (16.5 %) with follicular thyroid carcinoma (FTC), and 31 (32.0 %) with papillary thyroid carcinoma (PTC). In comparison with the features of benign nodules, FTC presented with a large nodule size, high serum Tg level, isoechogenicity, calcifications, and peripheral halo, whereas PTC exhibited traits similar to those of benign nodules, except for high serum Tg level and the presence of calcifications on ultrasonography. Therefore, a high serum Tg level (≥75 ng/mL) and calcification were the only significant predictive factors for malignancy in case of follicular neoplasm (p < 0.01). Serum Tg levels and the presence of calcification on ultrasonography are important clinical features to predict malignancy in thyroid nodules with cytological diagnosis of follicular neoplasm.

Entities:  

Mesh:

Year:  2013        PMID: 24014040     DOI: 10.1007/s12022-013-9263-x

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  30 in total

1.  Predictors of malignancy in patients with cytologically suspicious thyroid nodules.

Authors:  M Regina Castro; Rachel P Espiritu; Rebecca S Bahn; Michael R Henry; Hossein Gharib; Pedro J Caraballo; John C Morris
Journal:  Thyroid       Date:  2011-10-18       Impact factor: 6.568

2.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology.

Authors:  Guido Fadda; Esther Diana Rossi; Marco Raffaelli; Alfredo Pontecorvi; Stefano Sioletic; Francesca Morassi; Celestino Pio Lombardi; Gian Franco Zannoni; Guido Rindi
Journal:  Eur J Endocrinol       Date:  2011-07-01       Impact factor: 6.664

4.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

5.  Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features.

Authors:  Nese Ersoz Gulcelik; Mehmet Ali Gulcelik; Bekir Kuru
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-12

6.  Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration.

Authors:  R M Tuttle; H Lemar; H B Burch
Journal:  Thyroid       Date:  1998-05       Impact factor: 6.568

7.  Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Authors:  Armando Bartolazzi; Fabio Orlandi; Enrico Saggiorato; Marco Volante; Federico Arecco; Ruth Rossetto; Nicola Palestini; Ezio Ghigo; Mauro Papotti; Gianni Bussolati; Marco Paolo Martegani; Federico Pantellini; Angelo Carpi; Maria Rosaria Giovagnoli; Salvatore Monti; Vincenzo Toscano; Salvatore Sciacchitano; Gian Maria Pennelli; Caterina Mian; Maria Rosa Pelizzo; Massimo Rugge; Giancarlo Troncone; Lucio Palombini; Gennaro Chiappetta; Gerardo Botti; Aldo Vecchione; Rino Bellocco
Journal:  Lancet Oncol       Date:  2008-05-19       Impact factor: 41.316

8.  Utility of cell blocks in the diagnosis of thyroid aspirates.

Authors:  Niria Sanchez; Suzanne M Selvaggi
Journal:  Diagn Cytopathol       Date:  2006-02       Impact factor: 1.582

9.  Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.

Authors:  S Liu; R Semenciw; A M Ugnat; Y Mao
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

10.  Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules.

Authors:  Eun Kyung Lee; Ki-Wook Chung; Hye Sook Min; Tae Sung Kim; Tae Hyun Kim; Jun Sun Ryu; Yoo Seok Jung; Seok Ki Kim; You Jin Lee
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

View more
  7 in total

1.  Ultrasonographic risk factors of malignancy in thyroid nodules.

Authors:  A Rios; B Torregrosa; J M Rodríguez; D Rodríguez; A Cepero; M D Abellán; N M Torregrosa; A M Hernández; P Parrilla
Journal:  Langenbecks Arch Surg       Date:  2016-06-04       Impact factor: 3.445

2.  Risk Stratification in Patients With Follicular Neoplasm on Cytology: Use of Quantitative Characteristics and Sonographic Patterns.

Authors:  Ming-Hsun Wu; Kuen-Yuan Chen; Min-Shu Hsieh; Argon Chen; Chiung-Nien Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-30       Impact factor: 5.555

3.  Quantitative analysis of echogenicity for patients with thyroid nodules.

Authors:  Ming-Hsun Wu; Chiung-Nien Chen; Kuen-Yuan Chen; Ming-Chih Ho; Hao-Chih Tai; Yu-Hsin Wang; Argon Chen; King-Jen Chang
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

4.  Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.

Authors:  Narendra Hulikal; Azhagamuthu Re; Manilal Banoth; Amith Kumar Chowhan; Mutheswaraiah Yutla; Alok Sachan
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-02       Impact factor: 2.124

5.  Radiomics analysis improves 18FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules.

Authors:  Luca Giovanella; Lisa Milan; Arnoldo Piccardo; Gianluca Bottoni; Marco Cuzzocrea; Gaetano Paone; Luca Ceriani
Journal:  Endocrine       Date:  2021-09-01       Impact factor: 3.633

6.  EU-TIRADS-Based Omission of Fine-Needle Aspiration and Cytology from Thyroid Nodules Overlooks a Substantial Number of Follicular Thyroid Cancers.

Authors:  Tamas Solymosi; Laszlo Hegedüs; Miklos Bodor; Endre V Nagy
Journal:  Int J Endocrinol       Date:  2021-09-27       Impact factor: 3.257

7.  Analysis of Clinical-Radiological-Pathological Factors in FN/SFN Bethesda Category Thyroid Nodules, Contribution of FNAB Repeat, Single Center Experience.

Authors:  Ramazan Ucak; Deniz Turkyilmaz; Nurcihan Aygun; Cennet Sahin; Banu Yilmaz Ozguven; Fevziye Kabukcuoglu; Mehmet Uludag
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.